"LONG COVID"-A hypothesis for understanding the biological basis and pharmacological treatment strategy
Abstract Infection of humans with SARS‐CoV‐2 virus causes a disease known colloquially as "COVID‐19" with symptoms ranging from asymptomatic to severe pneumonia. Initial pathology is due to the virus binding to the ACE‐2 protein on endothelial cells lining blood vessels and entering these...
Saved in:
Main Authors: | Bevyn Jarrott (Author), Richard Head (Author), Kirsty G. Pringle (Author), Eugenie R. Lumbers (Author), Jennifer H. Martin (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2022-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Systems analysis shows that thermodynamic physiological and pharmacological fundamentals drive COVID‐19 and response to treatment
by: Richard J. Head, et al.
Published: (2022) -
The interacting physiology of COVID‐19 and the renin‐angiotensin‐aldosterone system: Key agents for treatment
by: Eugenie R. Lumbers, et al.
Published: (2022) -
Did our pharmacological strategy for COVID‐19 fail?
by: Jennifer H. Martin, et al.
Published: (2021) -
Critical insights to COVID‐19 disease and potential treatments using a systems analysis approach that integrates physiology, pharmacology, and clinical pharmacology
by: Jennifer H. Martin, et al.
Published: (2022) -
Thirteen ribs and long gap oesophageal atresia: The embryological hypothesis for exploration
by: Ramesh B Hatti, et al.
Published: (2020)